title: Imatinib mesilate inhibits melanogenesis in vitro.
authors.forename: M
authors.initials: M
authors.lastname: Cario-André
authors.forename: L
authors.initials: L
authors.lastname: Ardilouze
authors.forename: C
authors.initials: C
authors.lastname: Pain
authors.forename: Y
authors.initials: Y
authors.lastname: Gauthier
authors.forename: F-X
authors.initials: FX
authors.lastname: Mahon
authors.forename: A
authors.initials: A
authors.lastname: Taieb
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001549:Benzamides; D002478:Cells, Cultured; D004817:Epidermis / Q000187:drug effects; D006801:Humans; D000068877:Imatinib Mesylate; D008543:Melanins / Q000096:biosynthesis*; D008544:Melanocytes / Q000187:drug effects* / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D046509:Tissue Culture Techniques; D014820:Vitiligo / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D008543:Melanins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate